A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects
Clinical trial NCT03242239 · COMPLETED
Trial details
- NCT number
- NCT03242239
- Sponsor
- Alteogen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-09
- Primary completion
- 2016-08-04
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.